In the way of cervical cancer vaccines, consumers are still awaiting a wide variety of options. There are several groups who are currently developing vaccines against human papilloma virus, but in the way of commercially available vaccines, the only one readily available is the Merck groups Gardasil. Gardasil is a vaccine for girls and women aged nine to twenty six. Gardasil works best when given before a person has already had contact with human papilloma virus, but if a person has not had contact with all kinds of virus, then the vaccine will still protect against the other kinds of the virus. Gardasil uses a interesting, and somewhat clumsy, injection schedule. If the day of the first vaccination is “day one,” then two months after day one, a person gets the second shot, and six months after day one, a person gets the third shot. The three shots are necessary for Gardasil to work as best it can. The vaccine is relatively expensive, in the hundreds of dollars. The first commercial vaccinations will likely be taking place in January of 2007. Many people, mothers of teenagers and such, are anxious to get their loved ones vaccinated, so this will last.